Patents by Inventor Katalin Kalman

Katalin Kalman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ShK toxin compositions and methods of use
    Patent number: 6077680
    Abstract: Disclosed are methods and compositions comprising DNA segments, and proteins derived from sea anemone species. More particularly, it concerns the novel ShK toxin, ShK toxin analogs, chemically-modified toxin analogs, and nucleic acid segments encoding the ShK toxin from Stichodactyla helianthus. Various methods for making and using these DNA segments, DNA segments encoding synthetically-modified ShK toxins, and native and synthetic ShK peptides are disclosed, such as, for example, the use of DNA segments as diagnostic probes and templates for protein production, and the use of proteins, fusion protein carriers and peptides in various immunological and diagnostic applications.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: June 20, 2000
    Assignees: The University of Florida, Bachem Bioscience, Ing., Biomolecular Research Institute, Regents of the University of California
    Inventors: William R. Kem, Michael W. Pennington, Raymond S. Norton, K. George Chandy, Katalin Kalman
  • Transgenic plants expressing a prokaryotic ammonium dependent asparagine synthetase
    Patent number: 5723762
    Abstract: The gene asnA which encodes a prokaryotic ammonium-specific asparagine synthetase (ASN-A) can be introduced into plant cells. Such transformed cells and plants developed therefrom not only tolerate glutamine synthetase inhibitors but are effectively stimulated by such herbicides.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 3, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Denes Dudits, Katalin Paulovics, Katalin Kalman, Janos Gyorgyey, Ferenc Nagy, Laszlo Bako, Gabor Horvath, Peter Eckes, Gunter Donn
  • Voltage-gated potassium channel gene, KV1.7, vectors and host cells comprising the same, and recombinant methods of making potassium channel proteins
    Patent number: 5559009
    Abstract: This disclosure relates to the identification of a new voltage-gated potassium channel gene, Kv1.7, which is expressed in pancreatic .beta.-cells. The invention utilizes this new potassium channel for assays designed to identify extrinsic materials with the ability to modulate said channel for the development of therapeutics effective in the treatment of non-insulin-dependent diabetes mellitus.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: September 24, 1996
    Assignee: The Regents of The University of California
    Inventors: Kanianthara G. Chandy, Katalin Kalman, Grischa Chandy, George A. Gutman
  • Transgenic plants expressing a prokaryotic ammonium dependent asparagine synthetase
    Patent number: 5545819
    Abstract: The gene asnA which encodes a prokaryotic ammonium-specific asparagine synthetase (ASN-A) can be introduced into plant cells. Such transformed cells and plants developed therefrom not only tolerate glutamine synthetase inhibitors but are effectively stimulated by such herbicides.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: August 13, 1996
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Denes Dudits, Katalin Paulovics, Katalin Kalman, Janos Gyorgyey, Ferenc Nagy, Laszlo Bako, Gabor Horvath, Peter Eckes, Gunter Donn